These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 2048219)

  • 1. Cholecystokinin-dopamine interactions.
    Crawley JN
    Trends Pharmacol Sci; 1991 Jun; 12(6):232-6. PubMed ID: 2048219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholecystokinin modulation of locomotor behavior in rats is sensitized by chronic amphetamine and chronic restraint stress exposure.
    Wunderlich GR; Rotzinger S; Bush DE; DeSousa NJ; Vaccarino FJ
    Brain Res; 2004 Mar; 1001(1-2):95-107. PubMed ID: 14972658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrophysiological effects of diphenylpyrazolidinone cholecystokinin-B and cholecystokinin-A antagonists on midbrain dopamine neurons.
    Rasmussen K; Czachura JF; Stockton ME; Howbert JJ
    J Pharmacol Exp Ther; 1993 Jan; 264(1):480-8. PubMed ID: 8423546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioral and neurophysiological evidence for a facilatory interaction between co-existing transmitters: cholecystokinin and dopamine.
    Crawley JN; Hommer DW; Skirboll LR
    Neurochem Int; 1984; 6(6):755-60. PubMed ID: 20488104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholecystokinergic innervation of nucleus accumbens subregions.
    Lança AJ; De Cabo C; Arifuzzaman AI; Vaccarino FJ
    Peptides; 1998; 19(5):859-68. PubMed ID: 9663451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of cholecystokinin antagonists on the discriminative stimulus effects of cocaine in rats and monkeys.
    Massey BW; Vanover KE; Woolverton WL
    Drug Alcohol Depend; 1994 Jan; 34(2):105-11. PubMed ID: 8026297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological actions of cholecystokinin.
    Crawley JN; Corwin RL
    Peptides; 1994; 15(4):731-55. PubMed ID: 7937354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholecystokinin-induced excitation in the substantia nigra: evidence for peripheral and central components.
    Hommer DW; Palkovits M; Crawley JN; Paul SM; Skirboll LR
    J Neurosci; 1985 Jun; 5(6):1387-92. PubMed ID: 4009236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the effects of the cholecystokinin-B receptor antagonist, PD 134308, and the cholecystokinin-A receptor antagonist, L-364,718, on dopamine neuronal activity in the substantia nigra and ventral tegmental area.
    Meltzer LT; Christoffersen CL; Serpa KA; Razmpour A
    Synapse; 1993 Feb; 13(2):117-22. PubMed ID: 8446920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholecystokinin modulation of mesolimbic dopamine function: regulation of motivated behaviour.
    Rotzinger S; Bush DE; Vaccarino FJ
    Pharmacol Toxicol; 2002 Dec; 91(6):404-13. PubMed ID: 12688386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholecystokinin modulates mesolimbic dopaminergic influences on male rat copulatory behavior.
    Markowski VP; Hull EM
    Brain Res; 1995 Nov; 699(2):266-74. PubMed ID: 8616630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does cholecystokinin colocalize with dopamine in the human substantia nigra?
    Palacios JM; Savasta M; Mengod G
    Brain Res; 1989 May; 488(1-2):369-75. PubMed ID: 2743135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of acetylcholine release by cholecystokinin in striatum: receptor specificity; role of dopaminergic neuronal activity.
    Petkova-Kirova P; Giovannini MG; Kalfin R; Rakovska A
    Brain Res Bull; 2012 Dec; 89(5-6):177-84. PubMed ID: 22981453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microinjection of cholecystokinin into the rat ventral tegmental area potentiates dopamine-induced hypolocomotion.
    Crawley JN
    Synapse; 1989; 3(4):346-55. PubMed ID: 2740993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison between the pharmacology of dopamine receptors mediating the inhibition of cell firing in rat brain slices through the substantia nigra pars compacta and ventral tegmental area.
    Bowery B; Rothwell LA; Seabrook GR
    Br J Pharmacol; 1994 Jul; 112(3):873-80. PubMed ID: 7921615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholecystokinin- and dopamine-containing mesencephalic neurons provide distinct projections to monkey prefrontal cortex.
    Oeth KM; Lewis DA
    Neurosci Lett; 1992 Sep; 145(1):87-92. PubMed ID: 1361047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased neuronal responsiveness to cholecystokinin and dopamine induced by lesioning mesolimbic dopaminergic neurons: an electrophysiological study in the rat.
    Debonnel G; de Montigny C
    Synapse; 1988; 2(5):537-45. PubMed ID: 2903570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholecystokinin modulates the release of dopamine from the anterior and posterior nucleus accumbens by two different mechanisms.
    Marshall FH; Barnes S; Hughes J; Woodruff GN; Hunter JC
    J Neurochem; 1991 Mar; 56(3):917-22. PubMed ID: 1993898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Localization of cholecystokinin receptors in relation to the nigrostriatal and mesolimbic dopaminergic pathways.
    Gaudreau P; Quirion R; St-Pierre S; Chiueh CC; Pert A
    Neuropeptides; 1987; 9(4):283-93. PubMed ID: 3614556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholecystokinin-dopamine interactions within the nucleus accumbens in the control over behaviour by conditioned reinforcement.
    Phillips GD; Le Noury J; Wolterink G; Donselaar-Wolterink I; Robbins TW; Everitt BJ
    Behav Brain Res; 1993 Jun; 55(2):223-31. PubMed ID: 8357529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.